SR

Sunil Rajanikant Mehta

Active Director Whole-Time Director DIN 00118469
DIN 00118469 First appointment Jan 2001 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 5 historical roles
Total affiliations 7 Since Jan 2001
Shareholding value •••• Premium profile

About Sunil Rajanikant Mehta

Data last updated:

Sunil Rajanikant Mehta is a Whole-Time Director at Emcure Pharmaceuticals Limited (since 2013) and Director at Gennova Biopharmaceuticals Limited (since 2001). The companies operate in Pharma, Life Sciences and Paper. The 2 current companies with reported revenue have a combined latest revenue of ₹9,593 Cr; the largest is Emcure Pharmaceuticals Limited at ₹9,216 Cr (FY 2026). Earlier, Sunil Rajanikant Mehta was a Director at Emcutix Biopharmaceuticals Limited (2024) and Partner at Dolat Absolute Return Llp (2021) and 3 more.

DIN 00118469
Primary Designation Whole-Time Director
Industry Pharma
First Appointment 15 Jan 2001
Oldest Company Age 45 yrs
Largest company Emcure Pharmaceuticals Limited · ₹9,216 Cr (FY 2026)
Combined revenue ₹9,593 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Emcure Pharmaceuticals Limited L24231PN1981PLC024251
Whole-Time Director05 Jun 20131981₹9,216 Cr (FY 2026)Active
Gennova Biopharmaceuticals Limited U24231PN2001PLC016253
Director19 Jun 20012001₹376 Cr (FY 2023)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Emcutix Biopharmaceuticals Limited U21002PN2024PLC234721
Director03 Oct 20242024₹11.88 Cr (FY 2025)Active
Partner29 Jan 20212020₹37.07 Cr (FY 2025)Active
Lasor Pharmaceuticals Limited U24232PN2005PLC020815
Director01 Jun 20052005Amalgamated
Avet Lifesciences Private Limited U24299PN2020PTC193397
Director26 Aug 20202020₹1,801 Cr (FY 2025)Active
Emcure Infotech Limited U72100PN2000PTC015368
Director15 Jan 20012000Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Gennova Biopharmaceuticals Limited
Emcure Pharmaceuticals Limited
Emcure Infotech Limited
Emcutix Biopharmaceuticals Limited
Premium access

Shareholding and investment profile for Sunil Rajanikant Mehta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sunil Rajanikant Mehta

Sunil Rajanikant Mehta currently holds 2 directorships: Emcure Pharmaceuticals Limited (Whole-Time Director, since 05 Jun 2013, revenue ₹9,216 Cr (FY 2026)); Gennova Biopharmaceuticals Limited (Director, since 19 Jun 2001, revenue ₹376 Cr (FY 2023)).

Sunil Rajanikant Mehta was first appointed on 15 Jan 2001 as Director at Emcure Infotech Limited. The most recent appointment on record is 03 Oct 2024 at Emcutix Biopharmaceuticals Limited.

The 2 current companies of Sunil Rajanikant Mehta that report revenue have a combined latest revenue of ₹9,593 Cr: Emcure Pharmaceuticals Limited ₹9,216 Cr (FY 2026); Gennova Biopharmaceuticals Limited ₹376 Cr (FY 2023).

Sunil Rajanikant Mehta held 5 earlier board appointments: Emcutix Biopharmaceuticals Limited (Director, 03 Oct 2024 to 19 Dec 2024); Dolat Absolute Return Llp (Partner, 29 Jan 2021 to 25 Nov 2021); Lasor Pharmaceuticals Limited (Director, 01 Jun 2005 to 04 Feb 2010); Avet Lifesciences Private Limited (Director, 26 Aug 2020 to 23 Jul 2021); Emcure Infotech Limited (Director, from 15 Jan 2001).

The current boards of Sunil Rajanikant Mehta's companies include Amruta Balchandra Jana (Emcure Pharmaceuticals Limited), Chinnadharavaram Sundaresan Muralidharan (Emcure Pharmaceuticals Limited), Mukund Keshao Gurjar (Emcure Pharmaceuticals Limited), Namita Vikas Thapar (Emcure Pharmaceuticals Limited), Raman Pillai Raghu Kumar (Emcure Pharmaceuticals Limited), Samit Satish Mehta (Emcure Pharmaceuticals Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available